Akari Therapeutics (AKTX) Interest & Investment Income (2014 - 2025)
Akari Therapeutics recorded quarterly Interest & Investment Income of $1000.0 in Q3 2025, little changed quarter-over-quarter from $1000.0 in Q4 2024, and down 66.67% year-over-year from $3000.0 in Q3 2024.
Akari Therapeutics' Interest & Investment Income history runs 12 years deep, the most recent figure standing at $1000.0 for Q3 2025.
- In Q3 2025, Interest & Investment Income fell 66.67% year-over-year to $1000.0; the TTM figure through Dec 2025 stood at $5000.0 (down 37.5% YoY), while the FY2025 annual figure was $1000.0, down 87.5% from the prior year.
- Interest & Investment Income came in at $1000.0 for Q3 2025 at Akari Therapeutics, roughly flat from $1000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $30000.0 in Q1 2023 to a low of $1000.0 in Q4 2024.
- A 5-year average of $7327.8 and a median of $3735.0 in 2021 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income surged 633.25% in 2023 and sank 93.33% in 2024, its largest moves.
- Akari Therapeutics' Interest & Investment Income stood at $3979.0 in 2021, then dropped by 0.6% to $3955.0 in 2022, then surged by 76.99% to $7000.0 in 2023, then plunged by 85.71% to $1000.0 in 2024, then changed by 0.0% to $1000.0 in 2025.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $1000.0, $1000.0, and $3000.0 for Q3 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 19.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | 16,000.00 |
| Jun 30, 2023 | 29,000.00 |
| Mar 31, 2023 | 30,000.00 |
| Jun 30, 2022 | 3,955.00 |
| Mar 31, 2022 | 4,362.00 |
| Dec 31, 2021 | 3,979.00 |
| Sep 30, 2021 | 1,371.00 |
| Jun 30, 2021 | 1,515.00 |
| Mar 31, 2021 | 3,735.00 |
| Dec 31, 2020 | 5,321.00 |
| Sep 30, 2020 | 6,132.00 |
| Jun 30, 2020 | 1,152.00 |
| Mar 31, 2020 | 1,010.00 |
| Dec 31, 2019 | 1,739.00 |
| Sep 30, 2019 | 2,057.00 |
| Jun 30, 2019 | 449.00 |
| Mar 31, 2019 | 1,286.00 |
| Dec 31, 2018 | 24,110.00 |
| Sep 30, 2018 | 66,073.00 |
| Jun 30, 2018 | 67,436.00 |
| Mar 31, 2018 | 64,638.00 |
| Dec 31, 2017 | 51,036.00 |
| Sep 30, 2017 | 46,906.00 |
| Jun 30, 2017 | 38,564.00 |
| Mar 31, 2017 | 38,888.00 |
| Dec 31, 2016 | 45,398.00 |
| Sep 30, 2016 | 49,686.00 |
| Jun 30, 2016 | 17,307.00 |
| Mar 31, 2016 | 30,804.00 |
| Dec 31, 2015 | 19,260.00 |
| Sep 30, 2015 | 1,445.00 |
| Dec 31, 2014 | 6.00 |